Valuation: Enovis Corporation

Market Cap 1.1B 978M 912M 827M 1.56B 104B 1.57B 10.92B 4.28B 54.06B 4.11B 4.02B 173B P/E 2026 *
94x
P/E 2027 * 29x
Enterprise Value 2.4B 2.15B 2B 1.81B 3.41B 228B 3.44B 23.95B 9.38B 119B 9.02B 8.82B 380B EV / Sales 2026 *
1.03x
EV / Sales 2027 * 0.95x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day-2.50%
1 week+5.22%
Current month+1.42%
1 month+1.70%
3 months-24.83%
6 months-26.18%
Current year-30.44%
1 week 16.7
Extreme 16.7
19.12
1 month 16.7
Extreme 16.7
19.26
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
34.28
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
164.01
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
30/9/26 Free

Director

958 0.0017%
4/9/26 Buy

Chief Administrative Officer

2,660 0.0047%
4/9/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+5.22%-40.34%-61.86% 1.1B
-0.54%+3.41%-23.39%+10.76% 178B
-0.22%+8.38%-4.00%+29.17% 119B
-0.77%+1.73%-24.28%+6.09% 108B
+1.09%+0.89%-45.65%-10.67% 75.27B
+1.02%+5.13%+4.91%+78.49% 62.99B
+0.34%+0.40%+16.65%+62.51% 53.46B
-0.10%+3.79%-0.72%-28.01% 51.04B
+0.91%+3.70%-17.51%+22.32% 40.99B
-1.48%-0.53%+26.65%+6.21% 32.1B
Average -0.21%+2.71%-10.77%+11.50% 72.19B
Weighted average by Cap. -0.09%+3.15%-13.08%+18.20%

Financials

2026 *2027 *
Net sales 2.34B 2.09B 1.95B 1.77B 3.32B 222B 3.35B 23.33B 9.13B 115B 8.79B 8.59B 371B 2.45B 2.19B 2.04B 1.85B 3.49B 233B 3.51B 24.47B 9.58B 121B 9.21B 9.01B 389B
Net income 11.38M 10.16M 9.47M 8.59M 16.16M 1.08B 16.29M 113M 44.42M 562M 42.72M 41.78M 1.8B 29.72M 26.55M 24.75M 22.44M 42.23M 2.82B 42.56M 296M 116M 1.47B 112M 109M 4.71B
Net Debt 1.31B 1.17B 1.09B 986M 1.86B 124B 1.87B 13.03B 5.1B 64.48B 4.91B 4.8B 207B 1.25B 1.11B 1.04B 940M 1.77B 118B 1.78B 12.42B 4.86B 61.47B 4.68B 4.57B 197B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
15/10/26 USD 18.53 -2.42% 104,021
13/10/26 USD 18.99 +4.05% 1,405,755
12/10/26 USD 18.25 +3.17% 910,923
09/10/26 USD 17.69 +1.49% 1,146,638
08/10/26 USD 17.43 -1.02% 2,305,143
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.99USD
Average target price
36.08USD
Spread / Average Target
+90.01%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Enovis Corporation
  1. Stock Market
  2. Stocks
  3. ENOV Stock